Peptipedia
BioregulatorNot FDA ApprovedAnimal Studies

Vilon

Also known as Lys-Glu, KE Dipeptide

A synthetic dipeptide bioregulator targeting thymic function. Part of Khavinson's peptide bioregulator research for immune and anti-aging effects.

Available in Russia - Not FDA approved
CompareFind Vendors

Regulatory Pathway

Preclinical
Phase I
Phase II
Phase III
Phase IV
Approved

Dosing Protocol

Typical Dose

10-20 mg daily

Frequency

Once or twice daily

Duration

10-30 day courses

Community-reported dosing. Individual results vary. Not a medical recommendation.
Typical community protocol: 10-20 mg daily via Oral capsules or sublingual, Once or twice daily. Dose range: 10-20 mg daily. Duration: 10-30 day courses.

Timing & Administration

Administer via Oral capsules or sublingual. Frequency: Once or twice daily.

Mechanism of Action

Regulates gene expression in thymic and immune cells. Supports T-cell development and function, potentially reversing age-related thymic involution and immune decline.

Research Summary

Evidence level: animal studies. Clinical status: Available in Russia - Not FDA approved.

Side Effects & Safety

Important Warnings

  • Increased breast cancer in mouse models
  • Limited human safety data.
Generally well-tolerated
brief injection site discomfort

References

No references available.

Related Peptides

Browse all →
EpithalonBioregulator

A tetrapeptide studied for its effects on telomerase activation and potential anti-aging properties.

View profile
ThymalinBioregulator

A thymic peptide complex utilized in Russia for immune enhancement and longevity support, developed through Professor Khavinson's bioregulator peptide research.

View profile
PinealonBioregulator

A synthetic tripeptide bioregulator targeting brain tissue, designed to support cognitive function and neuroprotection as part of Khavinson's peptide research.

View profile